Karakousis G - Search Results

1

Prognostic Biomarkers in Melanoma: The Legacy of a Surgeon Scientist Who Followed the Data.

Karakousis G, Zager J. Karakousis G, et al. Ann Surg Oncol. 2022 May;29(5):2743-2744. doi: 10.1245/s10434-021-11273-7. Epub 2022 Jan 2. Ann Surg Oncol. 2022. PMID: 34974628 No abstract available.

2

Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.

Kesmodel SB, Karakousis GC, Botbyl JD, Canter RJ, Lewis RT, Wahl PM, Terhune KP, Alavi A, Elder DE, Ming ME, Guerry D, Gimotty PA, Fraker DL, Czerniecki BJ, Spitz FR. Kesmodel SB, et al. Ann Surg Oncol. 2005 Jun;12(6):449-58. doi: 10.1245/ASO.2005.04.027. Epub 2005 Apr 19. Ann Surg Oncol. 2005. PMID: 15864482

3

Predictors of regional nodal disease in patients with thin melanomas.

Karakousis GC, Gimotty PA, Botbyl JD, Kesmodel SB, Elder DE, Elenitsas R, Ming ME, Guerry D, Fraker DL, Czerniecki BJ, Spitz FR. Karakousis GC, et al. Ann Surg Oncol. 2006 Apr;13(4):533-41. doi: 10.1245/ASO.2006.05.011. Epub 2006 Mar 7. Ann Surg Oncol. 2006. PMID: 16523360

4

Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.

Karakousis GC, Gimotty PA, Czerniecki BJ, Elder DE, Elenitsas R, Ming ME, Fraker DL, Guerry D, Spitz FR. Karakousis GC, et al. Ann Surg Oncol. 2007 May;14(5):1596-603. doi: 10.1245/s10434-006-9319-y. Epub 2007 Feb 7. Ann Surg Oncol. 2007. PMID: 17285396

5

Regional recurrence after lymphadenectomy for clinically evident lymph node metastases from papillary thyroid cancer: a cohort study.

Shah PK, Shah KK, Karakousis GC, Reinke CE, Kelz RR, Fraker DL. Shah PK, et al. Ann Surg Oncol. 2012 May;19(5):1453-9. doi: 10.1245/s10434-011-1890-1. Epub 2011 Sep 13. Ann Surg Oncol. 2012. PMID: 21913023

6

Racial disparities in immediate breast reconstruction after mastectomy: impact of state and federal health policy changes.

Yang RL, Newman AS, Reinke CE, Lin IC, Karakousis GC, Czerniecki BJ, Wu LC, Kelz RR. Yang RL, et al. Ann Surg Oncol. 2013 Feb;20(2):399-406. doi: 10.1245/s10434-012-2607-9. Epub 2012 Oct 3. Ann Surg Oncol. 2013. PMID: 23054106

7

Sartorius transposition during inguinal lymphadenectomy for melanoma.

Bartlett EK, Meise C, Bansal N, Fischer JP, Low DW, Czerniecki BJ, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Bartlett EK, et al. J Surg Res. 2013 Sep;184(1):209-15. doi: 10.1016/j.jss.2013.04.033. Epub 2013 May 8. J Surg Res. 2013. PMID: 23688786

8

Local immune response predicts survival in patients with thick (t4) melanomas.

Cintolo JA, Gimotty P, Blair A, Guerry D, Elder DE, Hammond R, Elenitsas R, Xu X, Fraker D, Schuchter LM, Czerniecki BJ, Karakousis G. Cintolo JA, et al. Among authors: karakousis g. Ann Surg Oncol. 2013 Oct;20(11):3610-7. doi: 10.1245/s10434-013-3086-3. Epub 2013 Jul 10. Ann Surg Oncol. 2013. PMID: 23838911

9

Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: outcomes from the ACS NSQIP database.

Bartlett EK, Meise C, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Bartlett EK, et al. Ann Surg Oncol. 2014 May;21(5):1494-500. doi: 10.1245/s10434-013-3223-z. Epub 2013 Aug 29. Ann Surg Oncol. 2014. PMID: 23990289

10

Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.

Bartlett EK, Gimotty PA, Sinnamon AJ, Wachtel H, Roses RE, Schuchter L, Xu X, Elder DE, Ming M, Elenitsas R, Guerry D, Kelz RR, Czerniecki BJ, Fraker DL, Karakousis GC. Bartlett EK, et al. Ann Surg Oncol. 2014 Feb;21(2):643-9. doi: 10.1245/s10434-013-3313-y. Epub 2013 Oct 12. Ann Surg Oncol. 2014. PMID: 24121883 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

353 results

Search Page